Suboxone, Subutex, Addnok, Bunotex and Sangesic are all opiate treatment medications that have buprenorphine as the main ingredient for eliminating the discomfort associated with opiate withdrawal (heroin detox, oxycontin detox, methadone detox, norco detox).
Suboxone and Subutex are the brand name medications for Buprenorphine with Naloxone and Buprenorphine without Naloxone, respectively.
Sangesic, Addnok and Bunotex are the generic alternatives to Suboxone, Subutex and pure Buprenorphine. Sangesic, Bunotex and Addnok are manufactured in Asia and India by small pharmaceutical corporations (Rusan Pharma, Duopharma). The average cost per dose of the generic is below $1.25 per tablet. That is substantially below the brand name cost which runs in excess of $4.00 per tablet.
How does suboxone work?
Suboxone stimulates the mu receptors within the brain; replacing the previous opiate (Heroin, Oxycontin, Vicodin). Suboxone has a limited euphoric effect while simultaneously minimizing withdrawal symptoms associated with opiate abstinence syndrome.
Simply put, during a medical heroin detox a physician might use a combination of medications to minimize discomfort to such a degree that the probability of success is markedly improved. This sounds too good to be true but it is not. The key to success is an opiate specialty rehab center that ensures among other things:
- 24-hour supervision
- safe location
- individual counseling
- nutrition based program
- medication safety
How long does Suboxone stay in your system?
The average half life for suboxone is approximately 37 hours. That means that in 37 hours half of the main active ingredient (buprenorphine hydrochloride) will have been metabolized while the other half is still working within the central nervous system. The variation in half life depends on the individual’s unique metabolic rate and by the amount of suboxone taken.
For further Suboxone questions or information, please call toll free:
If medical heroin detox is combined with a state licensed opiate detox treatment program the likelihood of recidivism is measurably reduced. Alcohol and drug treatment programs that use every proven treatment model actually give clients an edge that could mean the difference between success and failure. You only want to this once so why not give yourself the best opportunity.
The buprenorphine hydrochloride is the medication that actually masks the symptoms associated with heroin withdrawal, oxycontin withdrawal and methadone withdrawal. The buprenorphine actually acts like a full agonist opiate by acting on mu receptors but acts like a partial agonist opiate by producing lower levels of dopamine more like a partial agonist opiate. The spectrum of receptors that are the bulk of analgesic and euphoric effect are the delta (brain), mu (brain) and kappa (spinal) receptors.
Suboxone Information California: Orange County Detox Center
Our treatment centers have found Suboxone to be effective in managing heroin withdrawal symptoms, oxycontin withdrawal symptoms and methadone withdrawal symptoms. A combination of physician oversight and an appropriate treatment program will give clients the best opportunity at a pain free opiate detox.
Suboxone Medical Heroin Detox Treatment Formula
Suboxone is approved for use with heroin treatment and other opiate opiate dependence programs. The main active ingredient within Suboxone is buprenorphine hydrochloride. It acts to reduce the symptoms of heroin withdrawal in just minutes if induction is handled properly. That is why physician oversight and 24-hour supervision inside a treatment center is critical.
Suboxone Medical Oxycontin Detox Treatment Formula
Suboxone is approved for use in treating Oxycontin withdrawal symptoms. The primary ingredient within Suboxone is buprenorphine. It works to minimize the effects associated with oxycontin withdrawal. Handled in conjunction with a residential treatment center can prove to be the most effective opiate treatment program available.
Federal Drug Treatment Act Of 2000 (Data)
This act permits physicians who meet certain qualifications to treat opiate addictions such as; heroin addiction, oxycontin addiction, methadone addiction and fentanyl addiction with Schedule III, IV and V medications approved by the Food and Drug Administration for that purpose. These medications may be prescribed and dispensed by waived physicians in treatment settings other than the traditional Opioid Treatment Programs (Methadone detox center).
Arcos Bulletin: October 7th, 2002
On October 7th, 2002 the DEA issued rule (6& FR 62354) which recategorized buprenorphine from a schedule V narcotic to a schedule III narcotic under the Controlled Substances Act (CSA).
For further information please contact ARCOS at: 202.307.8600
By Mail please write to:
Drug Enforcement Administration
Office of Diversion Control
Attn: Liaison and Policy Section
8701 Morissette Drive
Springfield, VA. 22152
800.882.9539
Suboxone And Subutex Approval: October 8th, 2002
On October 8th, 2002 the Food and Drug Administration officially approved Suboxone and Subutex use for treatment of opioid dependence.
Suboxone: Medication Safety
Because of Suboxone’s ceiling effect and poor bioavailability it is much safer from the possibility of overdose than a full agonist opioid like methadone or oxycontin. Approximately 95% of available opiate receptors will be filled by buprenorphine hydrochloride with a dosage of 16mg daily. The actual half-life of buprenorphine hydrochloride is just over 36 hours. The greater the dosage of Suboxone, the longer the half-life, that may extend out as long as 72 hours.
FOR FURTHER SUBOXONE INFORMATION PLEASE CALL TOLL FREE:
